KDIGO Guideline for Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
** THE UPDATED KDIGO CKD-MBD GUIDELINE WILL BE RELEASED IN Q2 2017 **
- European Renal Best Practice
Endorsement of the KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guidelines
- United Kingdom Renal Association
How do the KDIGO Clinical Practice Guidelines on CKD – MBD apply to the UK?
KDIGO is pleased to be able to provide the Guideline Executive Summary (Recommendation Statements only) in the following languages:
ΚΑΤΕΥΘΥΝΤΗΡΙΕΣ ΟΔΗΓΙΕΣ ΤΗΣ ΟΡΓΑΝΩΣΗΣ KDIGO ΓΙΑ ΤΗ ΔΙΑΓΝΩΣΗ, ΤΗΝ ΕΚΤΙΜΗΣΗ, ΤΗΝ ΠΡΟΛΗΨΗ ΚΑΙ ΤΗ ΘΕΡΑΠΕΙΑ ΤΗΣ ΔΙΑΤΑΡΑΧΗΣ ΤΟΥ ΜΕΤΑΒΟΛΙΣΜΟΥ ΤΩΝ ΟΣΤΩΝ ΚΑΙ ΤΩΝ ΜΕΤΑΛΛΙΚΩΝ ΣΤΟΙΧΕΙΩΝ ΣΤΗΝ ΧΡΟΝΙΑ ΝΕΦΡΙΚΗ ΝΟΣΟ (ΔΟΜ-ΧΝΝ)
We would like to express our appreciation to all who contributed to the translation of the CKD-MBD Guideline.
DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES
This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management.
Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.